INVENTORS
SHORT DESCRIPTION
This technique uses modified recurrence analysis on electrogram data to identify patient-specific arrhythmia drivers. It supports precise, tailored ablation mapping for atrial fibrillation.
BACKGROUND
Traditional atrial fibrillation mapping struggles with dynamic, variable electrogram morphologies and inconsistent cycle lengths. Existing ablation techniques often rely on anatomical targets, which may not capture all arrhythmia drivers. This gap leads to moderate success rates and highlights a significant clinical need for more reliable, patient-specific mapping methods.
ABSTRACT
The invention applies a modified recurrence plot analysis to sequential electrogram recordings. It identifies repetitive patterns and short cycle lengths that correlate with reentrant or focal AF drivers. The approach processes standard catheter data to improve mapping resolution and driver identification. Initial lab tests demonstrate its ability to discern potential arrhythmia sources, suggesting a considerable advancement over current methods.
MARKET OPPORTUNITY
The global market for atrial fibrillation treatment devices was valued at approximately $8.2 billion in 2024 and is projected to grow at a CAGR of over 13.5% through 2032 (Source: Global Market Insights, 2024).
DEVELOPMENT STAGE
TRL 4 - Prototype Validated in Lab: Key functions have been demonstrated using laboratory-scale electrogram recordings, confirming the analytical proof-of-concept.
APPLICATIONS
ADVANTAGES
PUBLICATIONS
IP STATUS
Issued US Patent 10,524,679